AGR2 and nasopharyngeal carcinoma: In the current study, we demonstrated that AGR2 coexpresses with CTSB/CTSD in NPC cells and tissues, and that downregulation of AGR2 by siRNA results in the reduction of the CTSB/CTSD expression in 6–10B cells with DNP treatment.